Doheny Campus Update
SriniVas Sadda, MD
President & Chief Scientific Officer
Dear Friends and Colleagues,
I am happy to bring you news that the initial design phase for our new campus in Pasadena is drawing to a close. Soon we will have detailed engineering plans and will be able to begin construction. Colleagues from across Doheny Eye Institute and UCLA Stein Eye Institute have generously lent their talents, insights and expertise to ensure not only that our new building is a state-of-the-art vision science research center, but that the design will have built-in flexibility so that accelerating advances in 21st century technology can be constantly integrated into our new facility. In other words, we are looking ahead and around corners.
Building a new home on a beautiful 7-acre campus is an enormous opportunity and responsibility. All of our design work has focused on Doheny’s three core functions: research, education and patient care. That focus will be reflected, both in the spaces you see and behind the scenes. We have diligently consulted with our doctors and assembled teams of stakeholders to share their top priorities and dreams for the space. My thanks to Dr. Bart Mondino, Chairman of the UCLA Department of Ophthalmology and Marissa Goldberg, our Executive Director at DEI, for their dedication to this task. Dr. Alfredo Sadun and Randy McGowen, DEI’s Director of Research Administration, have generously lent their abilities to lead the research advisory committee in reviewing and providing critical input on the design of the research laboratories. We are also indebted to Drs. John Irvine and Hugo Hsu, for ably steering the education committee’s visioning and planning to create a purpose-built conference center.
Building out 123,000 square feet with intention and anticipation for future needs and demands is an exciting task, entailing many iterations of detailed floor plans.
The process has fostered and prompted many conversations across DEI that will not only drive the building design, but also deepen our understanding of the potential of Doheny and the role that we all play within the institution, to our patients and to our colleagues in vision science. I am grateful for the time we have spent in these conversations, which I know strengthen both relationships and mission.
A significant bonus for us is that Pasadena continues to evolve as a global hub for bio tech activity, as Caltech, JPL, and the Huntington Medical Research Institute all spawn and attract new medical and tech enterprises and start-ups. We are well positioned to collaborate and benefit in myriad ways from the thinking and the ground-breaking science all around us. The timing for Doheny Eye Institute couldn’t be better to move into the future in our new home in 2020.
My thanks for your sustaining support throughout our growing process, and I look forward to seeing you there!